Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

May 2015 - FRMC

06/10/2015
Biologics for inflammatory bowel disease (IBD) can be administered as self-injection or infusion.
Biologics for inflammatory bowel disease (IBD) can be administered as self-injection or infusion.
Biologics for inflammatory bowel...
06/10/2015
First Report Managed Care
06/10/2015
Experts discuss biosimilars on the horizon and how the healthcare industry can prepare for biosimilar competition.
Experts discuss biosimilars on the horizon and how the healthcare industry can prepare for biosimilar competition.
Experts discuss biosimilars...
06/10/2015
First Report Managed Care
06/10/2015
An increased understanding of psoriasis pathophysiology has led to the release of new treatment targets.
An increased understanding of psoriasis pathophysiology has led to the release of new treatment targets.
An increased understanding of...
06/10/2015
First Report Managed Care
06/09/2015
Specialty drugs continue to make up a large portion of drug development and many specialty medications could soon see generic competition as the patents on 30 specialty products expire before 2020.
Specialty drugs continue to make up a large portion of drug development and many specialty medications could soon see generic competition as the patents on 30 specialty products expire before 2020.
Specialty drugs continue to make...
06/09/2015
First Report Managed Care
06/09/2015
Changes in the evolving healthcare environment are focusing on greater cooperation between providers and payers to improve quality of care while reducing cost.
Changes in the evolving healthcare environment are focusing on greater cooperation between providers and payers to improve quality of care while reducing cost.
Changes in the evolving...
06/09/2015
First Report Managed Care
06/09/2015
Oncology drugs rank second to cardiovascular drugs in terms of overall drug spend. Given the prevalence of varying types of cancers and the emotional and financial burdens many patients face, special attention is required when managing these...
Oncology drugs rank second to cardiovascular drugs in terms of overall drug spend. Given the prevalence of varying types of cancers and the emotional and financial burdens many patients face, special attention is required when managing these...
Oncology drugs rank second to...
06/09/2015
First Report Managed Care

Department

Conference Insider
06/10/2015
In 2014, only 1% of US prescriptions were specialty drugs, but they represented 31.8% of drug spend. This was a 27.7% increase from 2013, and specialty drug utilization in both the medical benefit and pharmacy benefit markets is expected to...
In 2014, only 1% of US prescriptions were specialty drugs, but they represented 31.8% of drug spend. This was a 27.7% increase from 2013, and specialty drug utilization in both the medical benefit and pharmacy benefit markets is expected to...
In 2014, only 1% of US...
06/10/2015
First Report Managed Care

Advertisement

Advertisement

Advertisement